Alnylam Pharmaceuticals, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US02043Q1076
USD
328.70
20.65 (6.7%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAlnylam Pharmaceuticals, Inc. VS Pharmaceuticals & Biotechnology
 
1D
6.7%
0%
1W
4.42%
-1.03%
1M
0.41%
-5.61%
YTD
-17.34%
-4.22%
1Y
16.99%
13.5%
3Y
73.02%
65.11%
5Y
143.05%
67.7%
10Y
445.29%
222.03%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-17.97%
0%
-17.97%
6 Months
-26.89%
0%
-26.89%
1 Year
16.99%
0%
16.99%
2 Years
116.15%
0%
116.15%
3 Years
73.02%
0%
73.02%
4 Years
100.66%
0%
100.66%
5 Years
143.05%
0%
143.05%

Alnylam Pharmaceuticals, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary